CommercialJune 30, 2019
Anthem Federal Employee Health Benefit Program® (FEP) PPO Members will now require prior approval for specific Specialty Drugs and Site of Care
List of medications by name and code
Code |
Procedure Description |
J0129 |
Abatacept injection (Orencia) |
J0490 |
Belimumab injection (Benlysta) |
J1459 |
Injection, immune globulin (Privigen) |
J1555 |
Injection, immune globulin (Cuvitru) |
J1556 |
Injection, immune globulin (Bivigam) |
J1557 |
Injection, immune globulin (Gammaplex) |
J1559 |
Injection, immune globulin (Hizentra) |
J1561 |
Injection, immune globulin (Gamunex-c/Gammaked) |
J1566 |
Injection, immune globulin (Carimune) |
J1568 |
Injection, immune globulin (Octagam) |
J1569 |
Injection, immune globulin, (Gammagard liquid) |
J1572 |
Injection, immune globulin , (Flebogamma) |
J1575 |
Injection, immune globulin/hyaluronidase (HyQvia) |
J1599 |
Injection, immune globulin (Panzyga) |
J1602 |
Golimumab IV (Simponi Aria) |
J1745 |
Infliximab not biosimilar (Remicade) |
J2323 |
Natalizumab injection (Tysabri) |
J3380 |
Vedolizumab Injection (Entyvio) |
Q5103 |
Infliximab dyyb biosimilar (Inflectra) |
Q5104 |
Infliximab abda biosimilar (Renflexis) |
Q5109 |
infliximab-qbtx, biosimilar (Ixifi) |
In addition to acquiring Prior Approval for the medication, the Outpatient Hospital Site of Care must also be approved. The Prior Approval process will identify members who meet the appropriate Anthem site of care criteria and who can safely receive their medication in a location other than an outpatient hospital, including the home.
Effective January 1, 2020 failure to receive Prior Approval for these medications may result in non-coverage of the medication and facility services.
To acquire Prior Approval please contact the Anthem Federal Employee Program Utilization Management Department at (800-860-2156).
To view this article online:
Or scan this QR code with your phone